Fortitude Family Office’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.81K Hold
323
– – ﹤0.01% 2059
2026
Q2
$1.83K Buy
323
+244
+309% +$1.19K ﹤0.01% 1511
2026
Q1
$339 Hold
79
– – ﹤0.01% 1814
2025
Q4
$708 Hold
79
– – ﹤0.01% 1585
2025
Q3
$292 Hold
79
– – ﹤0.01% 1904
2025
Q2
$154 Sell
79
-302
-79% -$629 ﹤0.01% 1980
2025
Q1
$671 Hold
381
– – ﹤0.01% 1062
2024
Q4
$1.01K Hold
381
– – ﹤0.01% 1139
2024
Q3
$872 Hold
381
– – ﹤0.01% 1114
2024
Q2
$1.11K Hold
381
– – ﹤0.01% 874
2024
Q1
$1.39K Hold
381
– – ﹤0.01% 874
2023
Q4
$575 Buy
+381
New +$490 ﹤0.01% 973

Other funds holding NUVB

Fortitude Family Office's NUVB Position: Q3 2026 in Review

Fortitude Family Office held its Nuvation Bio (NUVB) position steady in Q3 2026 at 323 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

Fortitude Family Office first reported a position in NUVB in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.83K in Q2 2026. 17 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Fortitude Family Office held 323 shares of Nuvation Bio worth $1.81K as of Q3 2026.
  • Fortitude Family Office left its Nuvation Bio share count unchanged in Q3 2026.
  • Nuvation Bio made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2059 holding.
  • Fortitude Family Office first reported a position in Nuvation Bio in Q4 2023 and has held it in 12 quarters since.
  • Fortitude Family Office's Nuvation Bio position peaked at $1.83K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.